Our goal is to develop improved synthetic
routes for the manufacture of
peptide-based new chemical entities (NCEs),
small proteins and peptide-containing
(bio)conjugates using the peptiligase technology

Our technology offers an entry into linear and cyclic peptide drugs, small proteins, (bio)conjugates, Antibody Drug Conjugates, PROTACs and LYTACs.